Steroid 5α-reductase 1 (5α-R1), a key enzyme in the conversion of steroids into their respective 5α-reduced derivatives, plays a key role in some hormone-dependent tumours and is abundant in the liver, although it is also widely distributed throughout the body. HGF (hepatocyte growth factor) is a pleiotropic cytokine/growth factor involved in the progression of hepatocellular carcinoma. In the present paper, we report the stimulatory effect of HGF on human 5α-R1 transcription in hepatocellular carcinoma cells. Pre-treatment with actinomycin D or cycloheximide blocked the up-regulation of 5α-R1 mRNA expression by HGF, indicating that the increased level of 5α-R1 mRNA expression is regulated by transcriptional activation and was dependent on de novo protein synthesis. Functional analysis of the 5 -flanking region of the 5α-R1 gene by transfection analysis showed that the − 79 to − 50 region functioned as the HGF-responsive region. Mutagenesis and electrophoretic mobility-shift assays demonstrated that induction of 5a-R1 by HGF is mediated by an Egr-1 (early growth-response gene 1)-binding site at − 60/− 54. In addition, overexpression of Egr-1 was sufficient to transactivate 5α-R1 promoter activity, and knockdown of Egr-1 with gene-specific small interfering RNA resulted in inhibition of HGF-induced up-regulation of endogenous 5α-R1 expression. These data provide the first evidence that HGF stimulates 5α-R1 expression through up-regulation of the transcription factor Egr-1, thus suggesting the possibility that regulation of steroid metabolism by HGF represents a mechanism for high risk of hepatocellular carcinogenesis in males.
INTRODUCTION
HCC (hepatocellular carcinoma), one of the most common malignancies, has a striking increased predominance in males [1] . Not only do males develop HCC more often than females, but also males die sooner than females once they develop the cancer. Various studies in experimental animal models have also shown that androgens are associated with an increased incidence of liver neoplasms. Agnew and Gardner [2] reported the increased incidence of hepatic tumours in mice chronically exposed to androgens. The elevation of hepatic androgen content has been observed in chemically induced hepatocarcinogenesis in rats [3] . Moreover, the growth and proliferation of hepatic tumour cell lines have been shown to be enhanced by DHT (dehydrotestosterone) and testosterone [4] . Furthermore, long-term use of androgenic steroids is associated with an increased risk of developing liver neoplasms, including HCC [5] [6] [7] [8] .
The enzyme 5α-R (steroid 5α-reductase) is a key enzyme in the conversion of several 4−3 -keto steroids, such as testosterone, progesterone and corticosterone, into more active androgens, such as DHT [9] [10] [11] . Two isoforms of 5α-R have been identified. Although these isoforms catalyse the same reaction, they possess different biochemical and pharmacological properties, and display distinct expression patterns in tissues [12] [13] [14] [15] . Type II (5α-R2) is the predominant enzyme in the prostate gland and other androgen-dependent organs [14] , whereas Type I (5α-R1) is widely distributed throughout the body and is abundant in the liver, where it catabolizes steroids. The correlation between androgens and HCC together with the predominant expression of 5α-R1 in liver may suggest an association between 5α-R1 and HCC. Although the localization of specific mRNA encoding 5α-R1 in liver has been elucidated, the regulation of gene expression remains obscure. Therefore understanding the regulation mechanism of 5α-R1 in HCC can help in identifying the importance of androgen metabolism in hepatocellular carcinogenesis.
HGF (hepatocyte growth factor) is a pleiotropic growth factor that is capable of inducing a variety of biological activities, including cellular proliferation, migration and invasiveness, by binding to its receptor c-Met. Numerous reports have examined the relationship between HGF/c-Met and HCC [16] [17] [18] [19] . c-Met overexpression has been found in HCC and is associated with metastasis and poor prognosis [20] . Serum HGF levels also have been found to be associated with the pathological features and the progression of HCC [21, 22] . HGF transgenic mice showed higher HCC risk in older animals [23] . Furthermore, HGF can induce numerous genes involved in metastasis and invasion of hepatoma cells, such as matrix metalloproteinase genes, uPA (urokinase-type plasminogen activator) and Ets-1 (E twenty-six 1) [24] . However, the relationship between HGF and androgen metabolism in HCC has not been reported.
In the present study, we found direct evidence that, in HCC cells, HGF induced the up-regulation of 5α-R1 through the transcription factor Egr-1 (early growth-response gene 1), suggesting a correlation between the HGF signal pathway and androgen metabolism in HCC.
Human HCC cell lines HepG2, Hep3B, Bel-7402 and SMMC-7721 were purchased from the Type Culture Collection of The Chinese Academy of Sciences, Shanghai, China. All cell lines were maintained in DMEM (Dulbecco's modified Eagle's medium) (Gibco ® ) with 10 % (v/v) fetal calf serum. Recombinant human HGF, Act D (actinomycin D) and CHX (cycloheximide) were purchased from Sigma-Aldrich.
RDA (cDNA representational difference analysis)
Double-stranded cDNA was prepared by RT (reverse transcription) of 2 μg of poly(A) mRNA using the Universal Riboclone ® cDNA Synthesis System (Promega). RDA was performed as described by Xu et al. [25] . Briefly, the driver representation consisted of cDNA generated from the pooled mRNA of normal HepG2 cells. This representation was subtracted from tester cDNA representation of the mRNA repertoire of HepG2 cells treated with HGF for 1 h. After three rounds of subtraction (driver excess: 50×, 400× and 10000× in successive rounds) and amplification, the entire third difference products were subcloned into the pGEM-T easy vector (Promega) and sequenced using the ABI Prism 3100 Genetic Analyzer (Applied Biosystems). A homology search of genes was performed using the online-based BLAST program at the NCBI.
RT-PCR
Total RNA was isolated using TRIzol ® (Gibco) and was reversetranscribed using RT-PCR kits (Promega) according to the manufacturer's instructions. The 5α-R1 forward primer was 5 -ATGGCAACGGCGACGGGGGTGGCGGAGG-3 , and the reverse primer was 5 -CAGGGCATAGCCACACCACTCCATG-ATT-3 . G3PDH (glyceraldehyde-3-phosphate dehydrogenase) was used as an internal control (G3PDH forward primer was 5 -ACCACAGTCCATGCCATCAC-3 , and the reverse primer was 5 -TCCACCACCCTGTTGCTGTA-3 ). The PCR products were electrophoresed on 1 % agarose gels and photographed under UV light.
Northern blotting
Northern blotting was performed as described previously [25] . Briefly, total RNA was fractionated on a 1 % agarose gel that contained 0.6 mol/l formaldehyde, transferred to a GeneScreen TM Plus membrane (PerkinElmer) and hybridized to 32 P-labelled cDNA probes. Hybridization to all probes was carried out at 68
• C in 6 × SSC (1 × SSC is 0.15 M NaCl/0.015 M sodium citrate), 5 × Denhardt's solution (0.02 % Ficoll 400/0.02 % polyvinylpyrrolidone/0.02 % BSA), 1 % SDS and 100 mg/ml single-stranded DNA. The blots were washed in 2 × SSC/0.05 % SDS for 20 min at room temperature (25 • C), followed by 20 min washes in 0.1 × SSC/0.1 % SDS at 50
• C before exposure to an Xray film. The probes for human 5α-R1 and G3PDH were generated by PCR.
Western blotting
Cells cultured on the plate were lysed with M-PER ® Mammalian Protein Extraction Reagent (Pierce) according to the manufacturer's instructions. Then, 20 μg of protein from each sample was loaded on to the gel. After separation by SDS/PAGE (10 % gels), proteins were transferred on to PVDF membranes and probed with various antibodies (all from Santa Cruz Biotechnology) at the following concentrations: antiEgr-1 (1:1000), anti-5α-R1 (1:500), and anti-β-actin (1:1000). Chemiluminescence detection was conducted using SuperSignal substrate (Pierce) according to the manufacturer's specifications.
Enzyme activity assay
The enzyme activity assay of 5α-R1 in cells was performed as described in [26] . Briefly, 10 6 cells were seeded in a six-well tissue culture plate and incubated overnight to allow the cells to attach. Then the cells were serum-starved for 12 h followed by treatment with 20 ng/ml HGF. After 8 h, [ 3 H]testosterone (PerkinElmer) was added at a concentration of 7.5 nM. Samples were taken at 60 min and measurement was performed. Sample treatment and HPLC analysis was performed as described by Reichert et al. [26] 
Plasmid constructions
The − 2647 to + 240 region relative to the transcription start site of 5α-R1 was PCR-amplified using primers: P − 2647, 5 -CC-CAAGCTTCGCTTAATTTGG CAGGGCGC-3 , and P + 240, 5 -CGACGCGTTACACTGAGTTCGTCTGACGAT-3 . The PCR product was digested with HindIII and NcoI and inserted in a promoterless luciferase reporter vector pGL3-basic (Promega), 
EMSA (electrophoretic mobility-shift assay)
The nuclear proteins were prepared using the NE-PER Nuclear and Cytoplasmic Extraction reagents (Pierce). The sequences of the upper strands of the oligonucleotides used for EMSA were Egr-1(− 70/− 45), 5 -CCCCGCCCCCGGGGCCGCACC-CACA-3 ; and mEgr-1(− 70/− 45), 5 -CCCCGCCCCCGGAAT-TGCACCCACA-3 . The oligonucleotide containing the Egr-1 consensus binding site 5 -CCCGGCGCGGGGGCGATTTCGA-GTCA-3 was used as reported previously [27] . Labelling, binding reactions, electrophoresis and detection were carried out with a Gel Shift Assay System (Promega) according to the manufacturer's instructions. For the competitor assay, a 50-fold excess of unlabelled double-stranded DNA was added to the reaction mixture before the addition of the labelled probe. For the supershift assay, antibodies against Egr-1 (Santa Cruz Biotechnology) were added to the EMSA mixture for 30 min at 4
• C. Antibodies against Egr-2 (Santa Cruz Biotechnology) and normal rabbit IgG were used as negative controls.
siRNA (small interfering RNA) transfection
The siRNA oligonucleotides of Egr-1 were synthesized by GenePharma Biotechnology as follows: sense, UUCUCCGAACGUGUCACGUdTdT; and antisense, ACGUGACACGUUCGGAGAAdTdT. The negative control (non-silencing) siRNA was obtained from Qiagen. RNAs were transfected into HepG2 cells using TransIT-TKO ® (Roche) at a concentration of 20 nM according to the manufacturer's instructions.
Transfection and luciferase assay
Cells were plated in six-well plate at a density of 2 × 10 5 cells/ well. Transfections were performed with Lipofectamine TM 2000 reagent (Invitrogen). The pRL-TK vector was used as an internal control and co-transfected. At 24 h after transfection, cells were harvested, and activities of firefly and Renilla luciferases were measured using the Dual-Luciferase Assay system (Promega). The activity of firefly luciferase was normalized to the activity of Renilla luciferase. All transfections and reporter assays were carried out each at least three times.
Statistical analysis
All experiments were performed at least three times. Data are reported as means + − S.E.M. and the statistical significance was assessed by one-way ANOVA followed by Students-NewmanKeuls tests. P 0.05 was considered to be significant.
RESULTS

5α-R1 can be induced transiently by HGF in human HCC cell lines
To isolate genes induced directly by HGF in human hepatoma cells, HepG2 cells were serum-starved for 12 h and then treated with 20 ng/ml recombinant human HGF for 1 h. Total RNA was extracted and an RDA was performed. After three rounds of subtraction and amplification, a total of 38 subtracted clones were randomly picked for sequencing analysis and a BLAST database search. Table 1 summarizes all the up-regulated genes. Among the 38 clones, eight clones were identical with 5α-R1, suggesting that 5α-R1 can be induced by HGF in HepG2 cells.
To confirm the effect of HGF on 5α-R1 expression, HepG2 cells were serum-starved for 12 h and then treated with 20 ng/ml HGF for various time periods as indicated ( Figure 1 ). Total RNA was extracted and subjected to RT-PCR ( Figure 1A ) and Northern blot analysis ( Figure 1B ). As Figure 1(A) shows, 5α-R1 mRNA expression was very low in untreated cells, increased gradually after HGF treatment, reaching a maximum level after 60 min, and decreased at 2 h. Western blot analysis was performed to analyse the effect of HGF on the protein level of 5α-R1. As shown in Figure 1 (C), HGF caused a pronounced induction of 5α-R1 protein expression, with a peak after 8 h. To confirm that the induction of the 5α-R1 protein correlated with the increased functional level, the enzyme activity of 5α-R1 was assayed. As shown in Figure 1(D) , the enzyme activity of 5α-R1 was also induced by HGF in HepG2 cells. To demonstrate further that the induction of 5α-R1 by HGF is a general phenomenon in hepatoma cells, several other human HCC cell lines such as Hep3B, Bel-7402 and SMMC-7721 were investigated and similar results were obtained ( Figures 1D and 1E) .
To probe into the mechanism of HGF-dependent 5α-R1 gene induction, HepG2 cells were pre-treated with the transcription inhibitor Act D (10 μM) or the protein synthesis inhibitor CHX (15 μg/ml), and the cells were then incubated in the presence or absence of HGF. Total RNA was prepared and subsequently RT-PCR analysis was performed. As Figure 1(F) shows, induction of 5α-R1 mRNA expression by HGF was blocked by pre-treatment with Act D, suggesting that the induction of 5α-R1 by HGF was regulated at the transcriptional level. In addition, the lack of increased 5α-R1 mRNA expression in the presence of CHX suggested that stimulation of 5α-R1 expression by HGF was dependent on new protein synthesis. Therefore these observations indicate that the up-regulation of 5α-R1 mRNA expression by HGF is mediated at the transcriptional level and requires de novo protein synthesis.
Isolation of the human 5α-R1 promoter
To analyse the molecular mechanism of HGF-dependent 5α-R1 gene induction in detail, we isolated a 2887 bp fragment containing a 2647 bp upstream sequence and a 240 bp downstream sequence from the transcription start site of 5α-R1 from human genomic DNA by PCR, and generated a reporter plasmid, pGL3-(− 2647/+ 240), by introducing the 2887 bp fragment into the promoterless plasmid pGL3-basic.
The pGL3-(− 2647/+ 240) vector was transfected into HepG2 cells, and the cells were treated with HGF at the concentration indicated (Figure 2) . After 24 h, the luciferase activities were measured. As shown in Figure 2 , the luciferase activity increased dramatically with increasing treatment with HGF compared with that exhibited by the HGF-untreated control. The results indicate that exposure to HGF resulted in increased 5α-R1 promoter activity and the potential cis-elements responsible for the HGF effect were present in the region − 2647/+ 240.
Identification of the HGF-responsive region in the 5α-R1 promoter
To identify specific DNA regions of the promoter that are responsible for HGF-induced stimulation of 5α-R1 promoter activity, a series of 5 -truncated plasmids were transiently transfected into HepG2 cells. After 24 h of HGF treatment, the luciferase activity was measured. As Figure 3 shows, the deletion of fragments from − 2647 to − 79 showed significant responsiveness to HGF with a 3-fold increase in promoter activity, whereas the deletion of − 79 to − 50 lost the responsiveness to HGF. The results indicate that the region between − 79 and − 50 contains essential elements for 5α-R1 induction by HGF. To elucidate further the molecular mechanism by which HGF stimulates 5α-R1 expression, we investigated the potential involvement of candidate transcription factors. Several studies have shown that HGF up-regulates many genes, including PDGF (platelet-derived growth factor) and VEGF (vascular endothelial growth factor) [28] , CD44v6 [29] , ACE (angiotensin-converting enzyme) [30] and fibronectin [31] , through Egr-1. A recent paper reported that, in HepG2 cells, HGF can induce Egr-1 [32] . Egr-1 is a nuclear zinc-finger transcription factor capable of binding to specific GC-rich DNA sequences containing the consensus binding site GCG(G/T)GGGCG [33] . A survey of the region − 79/− 50 using a program TFSEARCH (http://www.cbrc.jp/ research/db/TFSEARCH.html) also identified a putative Egr-1-binding site at − 60/− 54 ( Figure 4A ). To test whether the Egr-1-binding site at − 60/− 54 is functional, mutagenesis on the site was performed to alter the Egr-1 motif GGGGCC to GAATTC. The mutant constructs were transiently transfected into HepG2 cells, which were then treated with HGF. The luciferase activity assay showed that the mutation abolished the response to HGF, clearly indicating that the Egr-1 site − 60/− 54 was critical for the induction of 5α-R1 by HGF ( Figure 4B ).
HGF-induced Egr-1 binding to the Egr-1 consensus site at − 60/− 54
To examine whether Egr-1 bound to the site at − 60/− 54, EMSAs were performed using nuclear extracts from HGFtreated or untreated HepG2 cells and 32 P-labelled double-stranded fragments of − 70/− 45. As shown in Figure 5 (A), nuclear extracts from HGF-treated cells formed a stronger DNA-protein complex with the probe compared with extracts from control cells, suggesting that nuclear proteins recognizing the Egr-1-binding site were present in nuclear extracts of HepG2 cells treated with HGF. To confirm whether the protein complexes that bound to the site in the HepG2 nuclear extracts were indeed Egr-1, gelsupershift assays were undertaken with the Egr-1 antibody and nuclear extracts from HepG2 cells treated with HGF. As expected, the band disappeared upon addition of anti-Egr-1 antibody ( Figure 5A ). However, the antibody against Egr-2 and a normal rabbit IgG did not inhibit the formation of the DNA-protein complex. Competition experiments showed that the binding of Egr-1 was effectively and specifically inhibited by a 50-fold molar excess of either Egr-1 consensus oligonucleotide or the fragment − 70/− 45. In contrast, an excess of an oligonucleotide with a targeted mutation in the Egr-1 site (m− 70/− 45) did not affect the intensity of this band ( Figure 5B ).
All of these results suggest that up-regulation of 5α-R1 expression by HGF was associated with increased binding activity of Egr-1 protein to the Egr-1 site at − 60/− 54.
Transactivation of 5α-R1 promoter by Egr-1 protein
To determine directly whether Egr-1 protein could functionally modulate 5α-R1 promoter activity, pGL3-(− 79/+ 240) vector was co-transfected with the different doses of pCMV-Egr-1 vector indicated in Figure 6 (A) into HepG2 cells. The luciferase activity assay suggested that pCMV-Egr-1 stimulated the 5α-R1 promoter activity in a dose-dependent manner ( Figure 6A) . Moreover, overexpression of Egr-1 did not stimulate the luciferase activity of pGL3-m(− 79/+ 240) ( Figure 6B ) in which the Egr-1-binding site at − 60/− 54 was mutated. These results indicate that overexpression of Egr-1 transactivated the 5α-R1 promoter via the Egr-1-binding site at position − 60/− 54.
Egr-1 was induced by HGF stimulation in HepG2 cells
Since Egr-1 is an inducible intracellular signal transducer for HGF, we next examined the regulation of Egr-1 by HGF. HepG2 cells were made quiescent by serum starvation and then stimulated with HGF for up to 2 h. Results show that Egr-1 mRNA expression was very low in untreated HepG2 cells and increased gradually after HGF treatment, reaching a maximum level after 15 min and gradually decreasing at 2 h ( Figure 7A ). Western blot analysis demonstrated that HGF caused a pronounced induction of Egr-1 protein expression with a peak after 1 h ( Figure 7B ). These data suggest that HGF-induced 5α-R1 expression is mediated by the up-regulation of Egr-1 protein.
Knockdown of HGF-induced Egr-1 leads to down-regulation of HGF-induced 5α-R1 mRNA expression
To confirm the involvement of Egr-1 in HGF-induced endogenous 5α-R1 expression, we investigated the effect of Egr-1 knockdown by using an Egr-1 siRNA duplex. HegG2 cells were transfected with either a control non-silencing siRNA or Egr-1-specific siRNA, followed by treatment with or without HGF. To examine the silencing effect of Egr-1 siRNA, Western blot analysis was performed using anti-Egr-1 antibody and whole-cell lysates from untransfected, control siRNA-and Egr-1 siRNA-transfected cells supplemented with or without HGF. As shown in Figure 8 (A), in untransfected cells and cells transfected with the control siRNA, Egr-1 was highly expressed, reaching a maximum level at 1 h, and decreasing at 2 h, which is consistent with the results shown in Figure 7 (B). However, in cells transfected with Egr-1 siRNA, the Egr-1 level was reduced at all time points compared with the controls. The effect of Egr-1 knockdown on HGF-induced 5α-R1 expression was determined by Western blot analysis using wholecell lysates from cells treated with HGF as described above. As presented in Figure 8 (B), the transfection of HepG2 cells with the control siRNA did not show any inhibitory effect on HGF-induced 5α-R1 expression, whereas transfection with the Egr-1 siRNA led to down-regulation of HGF-induced 5α-R1 expression. These results indicate that the blockade of Egr-1 overexpression by siRNA prevented HGF-stimulated endogenous 5α-R1 expression and provided further evidence for the involvement of Egr-1 in the HGF-induced up-regulation of human 5α-R1 expression.
DISCUSSION
In the present study, we showed that HGF is a strong inducer of 5α-R1 in HepG2 cells. Luciferase activity and EMSA revealed that an Egr-1-binding site at − 60/− 54 was critical for the induction of 5α-R1 by HGF. Overexpression of Egr-1 significantly transactivated the promoter activity of 5α-R1. After HGF treatment, Egr-1 gene expression peaked by 1 h, followed by the peak in 5α-R1 gene expression 8 h later, consistent with the need for Egr-1 protein expression for induction of it. Furthermore, the blockade of Egr-1 overexpression by Egr-1-specific siRNA blocked endogenous HGF-induced 5α-R1 mRNA upregulation. These data provide evidence that HGF stimulated 5α-R1 expression through up-regulation of the transcription factor Egr-1. Enzymes involved in hormone metabolism can influence hormonal activities and risk of hormone-dependent cancers. 5α-R1 is well known as the enzyme that catalyses the conversion of testosterone into the more potent androgen DHT. The conversion of testosterone into DHT by 5α-R1 is implicated in various disease states, including benign prostatic hyperplasia androgenetic alopecia, hirsutism and cancer. Metabolism studies have shown that mammary tissues from several species including humans [34, 35] and several human breast cell lines [36, 37] exhibit 5α-R-metabolizing activities. Differences between tumorous and non-tumorous breast tissue in terms of relative activities of 5α-R have also been observed [35] . However, the expression and activity of 5α-R1 in HCC still remain obscure. In the present study, we demonstrated that 5α-R1 can be induced by HGF in HCC cells, which supports the possibility that induction of 5α-R1 by HGF may partly contribute to the high production of the active androgens in HCC and then lead to a high risk of HCC in males.
Previous studies have reported that 5α-R1 can be induced by various stimuli such as androgens in liver [38] , NGF (nerve growth factor) [39] and 5-hydroxytryptamine [40] in glioma cells. Further study shows that, in glioma cells, NGF induces the elevation of the 5α-R1 gene through expression of the transcription factor Egr-1. However, the detailed regulation mechanism of 5α-R1 and its 5 -upstream sequences or trans-or cis-acting factors for this gene still remain little known. In the present study, we characterized a 2887 bp fragment upstream of the 5α-R1 gene containing the elements responsible for HGF induction. Using deletion mutants and mutagenesis, we found that an Egr-1-binding site at − 60/− 54 was essential for the elevation of 5α-R1 by HGF.
Egr-1 was originally identified as an immediate-early gene product that is rapidly induced in response to a variety of extracellular stimuli and environmental stresses [41, 42] . Once activated, Egr-1 can bind to its target DNA sequences and induce numerous genes implicated in growth, differentiation and cancer progression [43] . Various studies suggest that Egr-1 is also a critical transcription factor in mediating HGF-induced expression of genes that are important for malignant progression and metastasis, such as ACE [30] , CD44v6 [29] and fibronectin matrix [31] . The prominent role of Egr-1 in the regulation of angiogenesis has also been described previously [28] . In the present study, we showed that Egr-1 was up-regulated in response to HGF in a human HCC cell line HepG2. This observation is in agreement with a previously reported effect of HGF on Egr-1 induction in a human hepatoma cell line [32] . Furthermore, the involvement of Egr-1 in the elevation of 5α-R1 induced by HGF also suggested that 5α-R1 might act as a target gene of Egr-1 in mediating the progression of HCC induced by HGF.
Although the Egr-1 element appeared to be essential in 5α-R promoter activity, this does not exclude the possibility of an involvement of other regulatory elements. The deletion mutant pGL3-514 showed a 2-fold increase in promoter activity compared with pGL3-728, indicating that the region between − 728 and − 514 may contain other critical negative regulatory elements. Identification of these transcription factors may facilitate understanding of the mechanism for transcriptional regulation of the 5α-R1 gene in liver cells.
In conclusion, data presented in this study are the first to demonstrate that the up-regulation of 5α-R1 in response to HGF is depended on an Egr-1-binding site on the promoter at − 60/− 54, suggesting a correlation between HGF and the enzyme involved in androgen metabolism in HCC.
